Skip to main content
Caplight Logo









Theta Neurotech

Theta Neurotech

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.thetaneurotech.com/

Last Round

Pre Seed

Nov 26, 2025

Total Funding Raised

$2.21M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Theta Neurotech is a neurotechnology company developing a wearable EEG-based seizure prediction system.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

seizure predictionwearable EEGneurotechepilepsy monitoringmedical AImedtechseizure alert devicebrain-computer interfaceBCIEEG sensorpredictive analyticswearable medical deviceremote patient monitoringdrug-resistant epilepsyHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Theta Neurotech Comparables

Compare Theta Neurotech with similar companies based on industry and business-model similarity.

Theta Neurotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quadlytics Inc.
79%
Epihunter
78%
Epiminder
75%

Theta Neurotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 26, 2025
GrantJun 17, 2025
AcceleratorJun 20, 2024

Key People

Founding team and executive leadership

Christopher Fitz

Co-Founder & CTO

Founding Team

Truman Pierson

Co-Founder & CEO

Founding Team

Theta Neurotech Investors

Notable investors and investment history

Theta Neurotech investors
InvestorRounds
Vaark VenturesPre Seed
Band of AngelsPre Seed
Polsky Center for Entrepreneurship and Innovation at the University of ChicagoGrant, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 3, 60% of headcount.

  • Nov 26, 2025

    $2M round led by Vaark Ventures

Theta Neurotech Filings

Explore SEC and related filing metadata, where available.

Theta Neurotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Theta Neurotech's valuation, stock price, and market status.

Is Theta Neurotech a public or private company?

Theta Neurotech is a private company.

What is the current stock price of Theta Neurotech?

Theta Neurotech is a private company with no public stock price. No recent secondary market data is available.

How much is Theta Neurotech worth (valuation)?

Valuation information for Theta Neurotech is not publicly available.

Can I buy Theta Neurotech stock?

Theta Neurotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Theta Neurotech's last funding round?

Theta Neurotech's most recent funding round was Pre Seed on November 26, 2025.

Who are the main investors in Theta Neurotech?

Key investors in Theta Neurotech include Vaark Ventures.

Will Theta Neurotech IPO soon?

No public IPO plans have been announced for Theta Neurotech.

How can I track Theta Neurotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theta Neurotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range5
Year Founded2022
Last FundingNov 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?